Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known which regimen of combination chemotherapy is most effective in treating advanced
colorectal cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of various combination
chemotherapy regimens in treating patients who have advanced, recurrent, or metastatic
colorectal cancer that cannot be treated with surgery or radiation therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborators:
National Cancer Institute (NCI) NCIC Clinical Trials Group